{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:29:02Z","timestamp":1776302942088,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.japh.2019.05.023","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T16:22:24Z","timestamp":1563034944000},"page":"736-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Description of a pharmacist-led diabetes prevention service within an employer-based wellness program"],"prefix":"10.1016","volume":"59","author":[{"given":"Courtney E.","family":"Gamston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna N.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Redden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather P.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly B.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2019.05.023_bib3","doi-asserted-by":"crossref","first-page":"44e51","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.japh.2019.05.023_bib4","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.japh.2019.05.023_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2337\/dc17-1376","article-title":"Health care spending on diabetes in the U.S., 1996\u20132013","volume":"41","author":"Suires","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.japh.2019.05.023_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.japh.2019.05.023_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the DPP outcomes study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.japh.2019.05.023_bib12","doi-asserted-by":"crossref","first-page":"e0125249","DOI":"10.1371\/journal.pone.0125249","article-title":"Receipt of glucose testing and performance of two US diabetes screening guidelines, 2007\u20132012","volume":"10","author":"Bullard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.japh.2019.05.023_bib18","author":"Spitalnic"},{"issue":"11","key":"10.1016\/j.japh.2019.05.023_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/JOM.0000000000000548","article-title":"Employer-based screening for diabetes and prediabetes in an integrated health care delivery system: a natural experiment for translation in diabetes (NEXT-D) study","volume":"57","author":"Adams","year":"2015","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.japh.2019.05.023_bib22","author":"Babey"},{"key":"10.1016\/j.japh.2019.05.023_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/1471-2458-14-573","article-title":"Barriers and facilitators for participation in health promotion programs among employees: a six-month follow up study","volume":"14","author":"Rongen","year":"2014","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.japh.2019.05.023_bib25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11606-016-3686-2","article-title":"Financial incentives and diabetes disease control in employees: retrospective cohort analysis","volume":"31","author":"Misra-Herbert","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.japh.2019.05.023_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4162\/nrp.2010.4.2.149","article-title":"Barriers to participation in a worksite wellness program","volume":"4","author":"Person","year":"2010","journal-title":"Nutr Res Pract"},{"issue":"3","key":"10.1016\/j.japh.2019.05.023_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systemic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.japh.2019.05.023_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1370\/afm.2035","article-title":"Systematic diabetes screening using point-of-care HbA1c testing facilitates identification of prediabetes","volume":"15","author":"Whitley","year":"2017","journal-title":"Ann Fam Med"},{"issue":"8","key":"10.1016\/j.japh.2019.05.023_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaophthalmol.2015.1312","article-title":"Cluster randomized trial assessing the effect on diabetes control of personalized diabetes complication risk assessment during ophthalmology exams","volume":"133","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.japh.2019.05.023_bib30","first-page":"43","article-title":"Comparing HbA1C by POC and HPLC","volume":"101","author":"Agrawal","year":"2018","journal-title":"R\u00a0I Med J (2013)"},{"issue":"8","key":"10.1016\/j.japh.2019.05.023_bib31","first-page":"888","article-title":"Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis","volume":"133","author":"Al-Ansary","year":"2015","journal-title":"JAMA Ophthalmol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:46:17Z","timestamp":1761543977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119302420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1544319119302420"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.023","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Description of a pharmacist-led diabetes prevention service within an employer-based wellness program","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}